BioMosae

Geleen, Netherlands · Founded 2018 · Privately Held (backing)

Developer of metabolite-based biofungicides designed to control plant diseases through non-living microbial compounds. BioMosae is based in Geleen, Netherlands and was founded in 2018. Its last reported valuation was $2.5 million in Sep 2022. It has raised $3.7 million.

Last reported valuation
$2.5M
Oct 2026
Priced at
—
Total raised
$3.7M
Last round
—

Who backs BioMosae?

2 investors
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

BioMosae investors

2 investors are on record for BioMosae, including StartLife and Limburg Development and Investment Company.

Free account
More of BioMosae with a free account
  • ·Watch BioMosae: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 2 firms already write checks for companies like BioMosae. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View